Sterne Agee Group’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Sterne Agee Group’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$2M	Buy	16,559 +293	+2%	+$33.1K	0.29%	100
2014 Q4	$1.66M	Sell	16,266 -187	-1%	-$18.3K	0.26%	126
2014 Q3	$1.53M	Sell	16,453 -267	-2%	-$23.2K	0.24%	128
2014 Q2	$1.38M	Sell	16,720 -433	-3%	-$33.1K	0.23%	143
2014 Q1	$1.31M	Sell	17,153 -310	-2%	-$24.2K	0.26%	139
2013 Q4	$1.21M	Sell	17,463 -15,015	-46%	-$985K	0.4%	70
2013 Q3	$2.1M	Buy	32,478 +3,866	+14%	+$245K	0.82%	30
2013 Q2	$1.67M	Buy	+28,612	New	+$1.63M	0.59%	51

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BTS

BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Sterne Agee Group's FBT Position: Q1 2015 in Review

Sterne Agee Group increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 1.8% in Q1 2015, buying an estimated $33.1K and bringing the position to 16,559 shares worth $2M. The position accounts for 0.29% of the portfolio, ranked #100.

Sterne Agee Group first reported a position in FBT in Q2 2013 and has held it in 8 quarters since. The position peaked at $2.1M in Q3 2013. 122 funds tracked by Wall St. Rank hold FBT as of Q1 2015.

Sterne Agee Group held 16,559 shares of First Trust NYSE Arca Biotechnology Index Fund worth $2M as of Q1 2015.
Sterne Agee Group bought 293 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2015, an estimated $33.1K.
First Trust NYSE Arca Biotechnology Index Fund made up 0.29% of Sterne Agee Group's portfolio in Q1 2015, its #100 holding.
Sterne Agee Group first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and has held it in 8 quarters since.
Sterne Agee Group's First Trust NYSE Arca Biotechnology Index Fund position peaked at $2.1M in Q3 2013.
122 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2015.

Based on Sterne Agee Group's 13F filing for Q1 2015, filed 13 May 2015.